Pioglitazone [111025-46-8]

Katalog-Nummer T0214-50mg

Size : 50mg

Marke : TargetMol


Pioglitazone

(Synonyms: U 72107) Copy Product Info
Hot
Pioglitazone (U 72107) is a PPARγ agonist with EC50 of 0.93 and 0.99 μM on human and mouse PPARγ, respectively, and has selective and oral activity. Pioglitazone can be used in diabetes research.
Pioglitazone
Cas No. 111025-46-8
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.82%
Color:White
COA HNMR LCMS

Product Information

Bioactivity
Description
Pioglitazone (U 72107) is a PPARγ agonist with EC50 of 0.93 and 0.99 μM on human and mouse PPARγ, respectively, and has selective and oral activity. Pioglitazone can be used in diabetes research.
Targets & IC50
PPARα (mouse):100 μM (EC50), PPARγ (human):0.93 μM (EC50), PPARα (human):100 μM (EC50), PPARγ (mouse):0.99 μM (EC50), PPARδ (human):43 μM (EC50)
In vitro
METHODS: HT-1080, MDA-MB-231, and PC-3 cells were treated with Pioglitazone for 3 days, and target cell toxicity was measured using MTT assay.
RESULTS: Pioglitazone did not affect cell growth at 100 μM. [1]
In vivo
METHODS: To investigate the effect of Pioglitazone on insulin resistance, Pioglitazone (10 and 30 mg/kg) was orally administered to ob/ob and adipo-/-ob/ob mice once daily for 14 days.
RESULTS: Pioglitazone improves insulin resistance and diabetes, which may be lipocalin-dependent in the liver but not in skeletal muscle. [2]
METHODS: To investigate the effect of Pioglitazone on cardiac remodeling, diabetic nephropathy rats were treated with oral administration of Pioglitazone (10 mg/kg) once daily for 4 weeks.
RESULTS: Pioglitazone significantly reduced body weight (BW), cardiac hypertrophy, elevated blood glucose levels, and related dyslipidemia. [3]
SynonymsU 72107
Chemical Properties
Molecular Weight356.44
FormulaC19H20N2O3S
Cas No.111025-46-8
SmilesC(C1C(=O)NC(=O)S1)C2=CC=C(OCCC3=CC=C(CC)C=N3)C=C2
Relative Density.1.26 g/cm3
Storage & Solubility Information
StorageStore under nitrogen Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 28.8 mg/mL (80.8 mM), Heating is recommended.
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
In Vivo Formulation
10% DMSO+90% Corn Oil: 2 mg/mL (5.61 mM), Sonication is recommended.
10% DMSO+40% PEG300+ 5% Tween 80 + 45% Saline: 2.88 mg/mL (8.08 mM), Solution.
10% DMSO+90% Saline: < 2.88 mg/mL (8.08 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8055 mL14.0276 mL28.0552 mL140.2761 mL
5 mM0.5611 mL2.8055 mL5.6110 mL28.0552 mL
10 mM0.2806 mL1.4028 mL2.8055 mL14.0276 mL
20 mM0.1403 mL0.7014 mL1.4028 mL7.0138 mL
50 mM0.0561 mL0.2806 mL0.5611 mL2.8055 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.